Risdiplam
Chemical compound
Risdiplam ▸ Facts ▸ Comments ▸ News ▸ Videos
Risdiplam, sold under the brand name Evrysdi, is a medication used to treat spinal muscular atrophy (SMA) and is the first oral medication approved to treat this disease by the US Food and Drug Administration (FDA).
| 0 shares | ShareTweetSavePostSend |
You Might Like
SC to govt: Why can't SMA med be as cheap in India as in Pakistan, China?The Supreme Court of India seeks responses from the Centre and Roche on making the spinal muscular atrophy treatment drug Risdiplam affordable in India. The move comes after it was reported that the..IndiaTimes - Published |
| Search this site and the web: |
